Colorectal carcinomas in 2013: The search for powerful prognostic markers is still on the go!

Cancer Biomarkers

Volumn 14, Issue 2-3, 2014, Pages 145-150

  Coget, Julien ^a   Borrini, Francesco ^b   Susman, Sergiu ^c   Sabourin, Jean Christophe ^a,d  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITY OF ROUEN   (France)

Author keywords

biomarkers; circulating tumor cells CTC; Colorectal carcinoma CRC; epithelial mesenchymal transitional process EMT

Indexed keywords

CYTOKERATIN; EPITHELIAL CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN;

ARTICLE; BLOOD CYTOLOGY; CANCER PROGNOSIS; CANCER TISSUE; CELL ISOLATION; CELL SEPARATION; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; HUMAN; IMMUNOMAGNETIC SEPARATION; LABORATORY DEVICE; MICROFLUIDICS; PRIORITY JOURNAL; COLORECTAL NEOPLASMS; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; FILTRATION; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS; TUMOR EMBOLISM;

ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; CYTOLOGICAL TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; FILTRATION; HUMANS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 84904369774     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130378     Document Type: Article

References (41)

1. R. Adam, V. Delvart, G. Pascal, A. Valeanu, D. Castaing, D. Azoulay, S. Giacchetti, B. Paule, F. Kunstlinger, O. Ghéard, F. Levi and H. Bismuth, Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival, Ann Surg 4 (2004), 644-57.
2. J.A. Aguirre-Ghiso, Models, mechanisms and clinical evidence for cancer dormancy, Nat Rev Cancer 11 (2007), 834-46.
3. T. André, C. Boni, M. Navarro, J. Tabernero, T. Hickish, C. Topham, A. Bonetti, P. Clingan, J. Bridgewater, F. Rivera and A. de Gramont, Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial, J Clin Oncol 19 (2009), 3109-16.
4. A.D. Benson, D. Schrag, M.R. Somerfield, A.M. Cohen, A.T. Figueredo, P.J. Flynn, M.K. Krzyzanowska, J. Maroun, P. McAllister, E. Van Cutsem, M Brouwers, M. Charette and D.G. Haller, American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer, J Clin Oncol 16 (2004), 3408-19.
5. A.M. Bouvier, Épidémiologie descriptive du cancer colorectal en France, Bull Epidem Hebdo 2-3 (2009), 14-16.
6. E.K. Broussard and M.L. Disis, TNM Staging in Colorectal Cancer: T Is for T Cell and M Is for Memory, J Clin Oncol 29 (2011), 601-3.
7. Y.S. Chang, E. di Tomaso, D.M. McDonald, R. Jones, R.K. Jain and L.L. Munn, Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood, Proc Natl Acad (2000), 14608-14613.
8. P.H Chapuis, O.F. Dent, R. Fisher, R.C. Newland, M.T. Pheils and E. Smyth, A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer, Br J Surg 9 (1985), 698-702.
9. K. Chevreul, Colorectal cancer in France, Eur J Health Econ 10 (2010), S15-S20.
10. S.J. Cohen, C.J. Punt, N. Iannotti, B.H. Saidman, K.D. Sabbath, N.Y. Gabrail, J. Picus, M.A. Morse, E. Mitchell, M.C. Miller, G.V. Doyle, H. Tissing, L.W. Terstappen and N.J. Meropol, Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer, Ann Oncol 7 (2009), 1223-1229.
11. C.C. Compton, Colorectal carcinoma: diagnostic, prognostic, and molecular features, Mod Pathol 4 (2003), 376-388.
12. Consensus conference. Prevention, diagnosis and treatment of colon cancer, Gastroenterol Clin Biol 2 (1998), 205-26.
13. M. Cristofanilli, G.T. Budd, M.J. Ellis, A. Stopeck, J. Matera, M.C. Miller, J.M. Reuben, G.V. Doyle, W.J. Allard, L.W. Terstappen and D.F. Hayes, Circulating tumor cells, disease progression, and survival in metastatic breast cancer, N Engl J Med 351 (2004), 781-91.
14. I. Desitter, B.S. Guerrouahen, N. Benali-Furet, J. Wechsler, P.A. Jänne, Y. Kuang, M. Yanagita, L. Wang, J.A. Berkowitz, R.J. Distel and Y.E. Cayre, A new device for rapid isolation by size and characterization of rare circulating tumor cells, Anticancer Res 2 (2011), 427-41.
15. Y.I. Elshimali and W.W. Grody, The clinical significance of circulating tumor cells in the peripheral blood, Diagnostic Molecular Pathology 4 (2006), 187-194.
16. S. Gill, C.L. Loprinzi, D.J. Sargent, S.D. Thomé, S.R. Alberts, D.G. Haller, J. Benedetti, G. Francini, L.E. Shepherd, J. Francois Seitz, R. Labianca, W. Chen, S.S. Cha, M.P. Heldebrant and R.M. Goldberg, Pooled analysis of fluorouracil-based adjuvant therapy for stage II and II colon cancer: Who benefits and by how much? J Clin Oncol 10 (2004), 1797-806.
17. L.L Gunderson, J.M. Jessup, D.J. Sargent, F.L. Greene and A.K. Stewart, Revised TN categorization for colon cancer based on national survival outcomes data, J Clin Oncol 2 (2010), 264-71.
18. L.E Harrison., J.G. Guillem, P. Paty and A.M. Cohen, Preoperative carcinoembryonic antigen predicts outcome in node negative colon cancer patients: a multivariate analysis of 572 patients, J Am Coll Surg 1 (1997), 55-9.
19. C. Hill and F. Doyon, La fréquence des cancers en France: mortalité en 2003, évolution depuis 1968 et cancers de l'enfant, Bull Cancer 1 (2007), 7-13.
20. V. Hofman, C. Bonnetaud, M.I. Ilie, P. Vielh, J.M. Vignaud, J.F. Fléjou, S. Lantuejoul, E. Piaton, N. Mourad, C. Butori, E. Selva, M. Poudenx, S. Sibon, S. Kelhef, N. Vénissac, J.P. Jais, J. Mouroux, T.J. Molina and P. Hofman. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker, Clin Cancer Res 4 (2011), 827-35.
21. V. Hofman, M.I. Ilie, E. Long, E. Selva, C. Bonnetaud, T. Molina, N. Vénissac, J. Mouroux, P. Vielh and P. Hofman, Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method, Int J Cancer 129 (2011), 1651-60.
22. V.J. Hofman, M.I. Ilie, C. Bonnetaud, E. Selva, E. Long, T. Molina, J.M. Vignaud, J.F. Fléjou, S. Lantuejoul, E. Piaton, C. Butori, N. Mourad, M. Poudenx, P. Bahadoran, S. Sibon, N. Guevara, J. Santini, N. Vénissac, J. Mouroux, P. Vielh and P.M. Hofman, Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls, Am J Clin Pathol 1 (2011), 146-56.
23. J.W. Huh, B.R. Oh, H.R. Kim and Y.J. Kim, Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer, J Surg Oncol 5 (2010), 396-400.
24. J.R. Jass, Y. Ajioka, J.P. Allen, Y.F. Chan, R.J. Cohen, J.M. Nixon, M. Radojkovic, A.P. Restall, S.R. Stables and L.J. Zwi, Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer, Histopathology 6 (1996), 543-8.
25. C. Liebig, G. Ayala, J. Wilks, G. Verstovsek, H. Liu, N. Agarwal, D.H. Berger and D. Albo, Perineural invasion is an independent predictor of outcome in colorectal cancer, J Clin Oncol 31 (2009), 5131-7.
26. C. Liebig, G. Ayala, J. Wilks, G. Verstovsek, H. Liu, N. Agarwal, D.H. Berger, D. Albo, J.M. Lloyd, C.M. McIver, S.A. Stephenson, P.J. Hewett, N. Rieger and J.E. Hardingham, Identification of early stage colorectal cancer patients at risk of relapse post-resection by immunobead transcription-PCR analysis of peritoneal lavage fluid for malignant cells, Clin Canc Res 12 (2006), 4217-24.
27. G. Lurje, M. Schiesser, A. Claudius and P. M. Schneider, Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications, J Oncol 2010, ID 392652.
28. B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea, T. Meatchi, P. Bruneval, Z. Trajanoski, W.H. Fridman, F. Pages and J Galon, Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction, J Clin Oncol 29 (2011), 610-618.
29. F. Nolé, E. Munzone, L. Zorzino, I. Minchella, M. Salvatici, E. Botteri, M. Medici, E. Verri, L. Adamoli, N. Rotmensz, A. Goldhirsch and M.T. Sandri, Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications, Ann Oncol 19 (2008), 891-7.
30. J. O'Connell, M.A. Maggard and C.Y. Ko, Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging, J Nat Cancer Inst 19 (2004), 1420-5.
31. S. Ogino, K. Nosho, N. Irahara, J.A. Meyerhardt, Y. Baba, K. Shima, J.N. Glickman, C.R. Ferrone, M. Mino-Kenudson, N. Tanaka, G. Dranoff, E.L. Giovannucci and C.S. Fuchs, Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype, Clin Cancer Res 2 (2009), 6412-20.
32. P. Paterlini-Brechot and N.L. Benali, Circulating tumor cells detection: clinical impact and future directions, Cancers Letters 253 (2007), 180-204.
33. P. Pinzani, B. Salvadori, L. Simi, S. Bianchi, V. Distante, L. Cataliotti, M. Pazzagli and C. Orlando, Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptasepolymerase chain reaction results and feasibility of molecu lar analysis by laser microdissection, Hum. Pathol 37 (2006), 711-718.
34. N.N. Rahbari, M. Aigner, K. Thorlund, N. Mollberg, E. Motschall, K. Jensen, M.K. Diener, M.W. Büchler, M. Koch and J. Weitz, Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer, Gastroenterology 138 (2010), 1714-1726.
35. J.P. Thiery and J.P. Sleeman. Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol 7 (2006), 131-142.
36. Y.H. Uen, S.R. Lin, D.C. Wu, Y.C. Su, J.Y. Wu, T.L. Cheng, C.W. Chi and J.Y. Wang, Prognosis significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection, Ann Surg 246 (2007), 1040-6.
37. Y.H. Uen, C.Y. Lu, H.L. Tsai, F.J. Yu, M.Y. Huang, T.L. Cheng, S.R. Lin and J.Y. Wang, Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I-III Colorectal Cancer after Curative Resection, Ann Surg Oncol 15 (2008), 2120-8.
38. H. Ueno, H. Mochizuki, Y. Hashiguchi, H. Shimazaki, S. Aida, K. Hase, S. Matsukuma, T. Kanai, H. Kurihara, K. Ozawa, K. Yoshimura and S. Bekku, Risk factors for an adverse outcome in early invasive colorectal carcinoma, Gastroenterol 2 (2004), 385-94.
39. G. Vona, L. Estepa, C. Béroud, D. Damotte, F. Capron, B. Nalpas, A. Mineur, D. Franco, B. Lacour, S. Pol, C. Bréchot and P. Paterlini-Bréchot, Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer, Hepatology 39 (2004), 792-797.
40. J.Y. Wang, S.R. Lin, D.C. Wu, C.Y. Lu, F.J. Yu, J.S. Hsieh, T.L. Cheng, L.B. Koay and Y.H. Uen, Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels, Clin Cancer Res 13 (2007), 2406-13.
41. J.Y. Wang, C.H. Wu, C.Y. Lu, J.S. Hsieh, D.C. Wu, S.Y. Huang and S.R. Lin, Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis, World J Surg 30 (2006), 1007-13.